Circular RNA in Non-small Cell Lung Carcinoma: Identification of Targets and New Treatment Modalities.

Weidle, Ulrich H; Birzele, Fabian

Weidle, Ulrich H; Birzele, Fabian.

Affiliation

Weidle UH; Roche Pharma Research and Early Development, Roche Innovation Center Munich, Penzberg, Germany; weidle49@t-online.de.
Birzele F; Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, Basel, Switzerland fabian.birzele@roche.com.

Cancer Genomics Proteomics ; 20(6suppl): 646-668, 2023 Dec.

Article in En | MEDLINE | ID: mdl-38035705

Subject(s)

Carcinoma, Non-Small-Cell Lung; Lung Neoplasms; MicroRNAs; Humans; Animals; Mice; RNA, Circular/genetics; Carcinoma, Non-Small-Cell Lung/genetics; Carcinoma, Non-Small-Cell Lung/therapy; Lung Neoplasms/genetics; Lung Neoplasms/therapy; MicroRNAs/genetics; MicroRNAs/metabolism; RNA, Messenger/genetics; RNA, Small Interfering

Key words

Druggability; review; shRNA; short hairpin RNA; siRNA; small interfering RNA; target identification and validation; xenograft models

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / MicroRNAs / Lung Neoplasms Limits: Animals / Humans Language: En Journal: Cancer Genomics Proteomics Journal subject: BIOQUIMICA / GENETICA MEDICA / NEOPLASIAS Year: 2023 Type: Article

Fulltext

XML

PubMed Links

Search on Google